Another plausible explanation lies in the concentration range of PI fractions used during and after infection of the Vero E6 cell line: the concentration of cathepsin L inhibitors — selected following the cell viability tests — was too low to neutralize cathepsin L protease activity. The gene discussed is CTSL; the disease is infection.